Cargando…
Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts
BACKGROUND: Natural extracts play an important role in traditional medicines for the treatment of diabetes mellitus and are also an essential resource for new drug discovery. Dipeptidyl peptidase IV (DPP-IV) inhibitors are potential candidates for the treatment of type 2 diabetes mellitus, and the e...
Autores principales: | Guasch, Laura, Sala, Esther, Ojeda, María José, Valls, Cristina, Bladé, Cinta, Mulero, Miquel, Blay, Mayte, Ardévol, Anna, Garcia-Vallvé, Santiago, Pujadas, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448616/ https://www.ncbi.nlm.nih.gov/pubmed/23028712 http://dx.doi.org/10.1371/journal.pone.0044972 |
Ejemplares similares
-
Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays
por: Guasch, Laura, et al.
Publicado: (2012) -
Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity
por: Guasch, Laura, et al.
Publicado: (2013) -
Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation
por: Guasch, Laura, et al.
Publicado: (2012) -
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
por: Yin, Ruili, et al.
Publicado: (2022) -
Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
por: Chalichem, Nehru Sai Suresh, et al.
Publicado: (2021)